Otophylloside L

CAS No. 1015447-52-5

Otophylloside L( ——— )

Catalog No. M39074 CAS No. 1015447-52-5

Otophylloside L is a pregnane glycosides isolated from the roots of Cynanchum otophyllum. Otophylloside L can be used in epilepsy research.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
25MG Get Quote Get Quote
50MG Get Quote Get Quote
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Otophylloside L
  • Note
    Research use only, not for human use.
  • Brief Description
    Otophylloside L is a pregnane glycosides isolated from the roots of Cynanchum otophyllum. Otophylloside L can be used in epilepsy research.
  • Description
    Otophylloside L is a pregnane glycosides isolated from the roots of Cynanchum otophyllum. Otophylloside L can be used in epilepsy research.
  • In Vitro
    ———
  • In Vivo
    ———
  • Synonyms
    ———
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ———
  • Research Area
    ———
  • Indication
    ———

Chemical Information

  • CAS Number
    1015447-52-5
  • Formula Weight
    1246
  • Molecular Formula
    C61H98O26
  • Purity
    >98% (HPLC)
  • Solubility
    ———
  • SMILES
    ———
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Ma XX, et al. New pregnane glycosides from the roots of Cynanchum otophyllum. Steroids. 2007 Oct;72(11-12):778-86.?
molnova catalog
related products
  • KM1954

    N-(3,5-Bis(trifluoromethyl)phenyl)-2-chloroacetamide is an insecticide, it is most active against 1st stage Ae. aegypti larvae with LC50 values of 125μM.

  • DATPT

    DATPT is a small molecule 12WLVSKF17 peptide mimetic molecule.DATPT inhibits SNX9-p47phox interactions and inhibits the production of reactive oxygen species and inflammatory cytokines.

  • BT173

    BT173 is a novel inhibitor of homeodomain interacting protein kinase 2 (HIPK2 ), attenuating renal fibrosis through suppression of the TGF-?1/Smad3 pathway.